Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
BJOG : an International Journal of Obstetrics and Gynaecology|August 29, 2021
Polycystic ovary syndrome and risk of stillbirth: a nationwide register-based studyH Valgeirsdottir, T Kunovac Kallak, I Sundström Poromaa, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|December 2, 2022
Women's decision-making related to induced abortion - a cross sectional study during a period of Covid-19 pandemic, in SwedenM Makenzius, C Obern, T Tydén, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 14, 2018
Prenatal exposures and birth indices, and subsequent risk of polycystic ovary syndrome: a national registry-based cohort studyH Valgeirsdottir, E Vanky, I Sundström-Poromaa, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 27, 2021
There is no association between combined oral hormonal contraceptives and depression: a Swedish register-based cohort studyC Lundin, A Wikman, E Lampa, et al.
Climacteric : the Journal of the International Menopause Society|May 8, 2013
Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patientsJ Baumgart, K Nilsson, A Stavreus Evers, et al.
Frontiers in Cellular Neuroscience|June 5, 2013
The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspringJ D A Olivier, H Akerud, H Kaihola, et al.
International Review of Neurobiology|October 16, 2001
Neuroactive steroids and central nervous system disordersM Wang, T Bäckström, I Sundström, et al.
Archives of Women'S Mental Health|November 6, 2014
Personality and risk for postpartum depressive symptomsS I Iliadis, P Koulouris, M Gingnell, et al.
Scientific Reports|November 28, 2019
Thromboinflammatory changes in plasma proteome of pregnant women with PCOS detected by quantitative label-free proteomicsR K Arffman, M Saraswat, S Joenväärä, et al.
Psychoneuroendocrinology|May 16, 2015
Treatment with serotonin reuptake inhibitors during pregnancy is associated with elevated corticotropin-releasing hormone levelsA-K Hannerfors, C Hellgren, D Schijven, et al.
Pageof 5